A61P 1 - Drugs for disorders of the alimentary tract or the digestive system

Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/2002
11/21/2002	WO2002091993A2 Estrogen receptor modulators
11/21/2002	WO2002091955A1 Artificial kidney having function of metabolizing protein and mehtod of constructing the same
11/21/2002	WO2002091850A1 Method for producing a nutrition additive, an additive and its use
11/21/2002	WO2002091833A1 Prebiotic and probiotic compositions and methods for their use in gut-based therapies
11/21/2002	WO2002078615A3 Antioxidant nitroxides and nitrones as therapeutic agents
11/21/2002	WO2002074309A3 Use of tryptophan derivatives for the specific cytostatic treatment of serotonin-producing tumors
11/21/2002	WO2002067870A3 Composition and method for preventing and treating sinusoidal obstruction syndrome and radiation-induced liver disease
11/21/2002	WO2002062343A3 PHARMACEUTICAL FORMULATION COMPRISING PYRAZOLO[4,3-d]PYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS OR THIENOPYRIMIDINES AND ENDOTHELIN RECEPTOR ANTAGONISTS
11/21/2002	WO2002058792A3 Rehydration composition
11/21/2002	WO2002055514A3 Substituted benzimidazol-2-ones as vasopressin receptor antagonists and neuropeptide y modulators
11/21/2002	WO2002049649A3 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives (2)
11/21/2002	WO2002018341A9 Quinoline- (c=o) - (di-, tri- and tetrapeptide) derivatives as caspase inhibitors
11/21/2002	WO2001042273A9 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders
11/21/2002	WO2001019397A9 Methods and compositions utilizing rad51
11/21/2002	US20020173661 Phosphodiesterase-4 (PDE4); thiazole-containing pyridine (N-oxide) compounds; 4-(2-(3,4-Bis(difluoromethoxy)phenyl)-2-(5-(2-(1-hydroxy-1 -methyl)ethyl)thiazolyl)ethyl)pyridine N-oxide for example
11/21/2002	US20020173658 Administering to a mammal a substituted 2-(2,6-dioxopiperidin-3-yl)phthalimides and 1-oxo-2-(2,6-dioxopiperidin-3-yl)isoindolines to reduce the levels of tumor necrosis factor-alpha to treat autoimmune diseases
11/21/2002	US20020173655 Thioether substituted imidazoquinoline or tetrahydroimdazoquinoline compounds induce the biosynthesis of cytokines such as interferon and useful for treating viral disease in an animal
11/21/2002	US20020173641 Nucleotide sequences coding polypeptides for use in human therapeutics, pharmacology and diagnostics
11/21/2002	US20020173528 Agonists specific for the peripheral cannabinoid receptor
11/21/2002	US20020173521 Inhibitors of copper-containing amine oxidases
11/21/2002	US20020173514 Pyridine-substituted pyrazolopyridine derivatives
11/21/2002	US20020173510 Nutrient mixture; fatty acid, calcium compound and vitamins
11/21/2002	US20020173507 Antiproliferative agents; apoptosis; anticancer agents
11/21/2002	US20020173503 Substituted pyridoindoles as serotonin agonists and antagonists
11/21/2002	US20020173500 Hypotensive agents; antiischemic agents
11/21/2002	US20020173499 Estrogen replacement therapy
11/21/2002	US20020173485 Mixture of hyaluronic acid and polyvinylpyrrolidone
11/21/2002	US20020173460 Complexing with fibronectins; analyzing, calibration; antiinflammatory agents, respiratory system disorders
11/21/2002	US20020172661 For diagnosis, prevention, or treatment of diseases responsive to therapy with interferon- beta (IFN-beata)
11/21/2002	CA2447576A1 Use of hmg fragment as anti-inflammatory agents
11/21/2002	CA2447518A1 Therapeutic use of rank antagonists
11/21/2002	CA2447305A1 Novel 5-phenyl-1h-indole derivatives as antagonists of interleukine-8 receptors
11/21/2002	CA2447292A1 Peptide compounds for counteracting reactive oxygen species and free radicals
11/21/2002	CA2447184A1 5-cyano-1h-indole derivatives as antagonists of the interleukine-8 receptors
11/21/2002	CA2447116A1 Methods for treating liver disease and liver damage with growth hormone and foxm1b
11/21/2002	CA2447050A1 Nucleic acid molecules encoding a transmembrane serine protease 10, the encoded polypeptides and methods based thereon
11/21/2002	CA2447015A1 Insulin producing cells derived from human embryonic stem cells
11/21/2002	CA2446988A1 The citrate salt of 5, 8, 14-triazatetracyclo(10.3.1.02,11.04.9)-hexadeca-2(11),3,5,7,9-pentaene and pharmaceutical compositions thereof
11/21/2002	CA2446980A1 Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
11/21/2002	CA2446879A1 2,5-disubstituted pyridine, pyrimidine, pyridazine and 1, 2, 4-triazine derivatives for use as p38 inhibitors
11/21/2002	CA2446747A1 Thyroid hormone receptor antagonists for cardiac and metabolic disorders ii
11/21/2002	CA2446717A1 Novel 4-anilinoquinoline-3-carboxamides
11/21/2002	CA2446593A1 Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient
11/21/2002	CA2446586A1 Aromatic sulfone hydroxamates and their use as protease inhibitors
11/21/2002	CA2446180A1 Cytokine polypeptides
11/21/2002	CA2446106A1 System for delivering cosmetics and pharmaceuticals
11/21/2002	CA2445922A1 Estrogen receptor modulators
11/21/2002	CA2445606A1 Taste masking pharmaceutical composition
11/21/2002	CA2445366A1 Molecules for disease detection and treatment
11/21/2002	CA2445003A1 Diarylurea derivatives useful as anti-inflammatory agents
11/21/2002	CA2443191A1 Compositions for transmucosal administration containing coenzyme q as the active ingredient
11/21/2002	CA2442635A1 Gastrokines and derived peptides including inhibitors
11/20/2002	EP1258251A1 Compositions for preventing and treating digestive diseases
11/20/2002	EP1257822A1 Her-2 binding antagonists
11/20/2002	EP1257645A2 Fibroblast growth factor-23 molecules and uses thereof
11/20/2002	EP1257635A2 Lipid metabolism enzymes and polynucleotides encoding them
11/20/2002	EP1257585A2 Antibodies that bind human interleukin-18 and methods of making and using
11/20/2002	EP1257578A2 Transporters and ion channels
11/20/2002	EP1257563A1 Therapeutic and diagnostic methods for ulcerative colitis and associated disorders
11/20/2002	EP1257556A1 Thiazolopyrimidines and their use as modulators of chemokine receptor activity
11/20/2002	EP1257555A1 Pyrimidine compounds and their use as modulators of chemokine receptor activity
11/20/2002	EP1257554A1 Benzoxathiepino[3,4-b]pyridine derivatives, process for their preparation and their use as medicaments
11/20/2002	EP1257553A1 Pyrrolopyrimidinone derivatives, process of preparation and use
11/20/2002	EP1257548A1 Benzofuran carboxamides and their therapeutic use
11/20/2002	EP1257546A1 Kinase inhibitors
11/20/2002	EP1257543A1 Pyridinylimidazoles
11/20/2002	EP1257539A2 Amino pyrazole derivatives useful for the treatment of obesity and other disorders
11/20/2002	EP1257536A1 Substituted nicotinamides and analogs as activators of caspases and inducers of apoptosis and the use thereof
11/20/2002	EP1257528A1 Aminoalcohol derivatives
11/20/2002	EP1257527A1 (2s)-aminoindan derivatives, a process for their preparation and their use as selective dopamine d3 ligands
11/20/2002	EP1257298A1 Cosmid dna constructs and methods of making and using the same
11/20/2002	EP1257292A1 Use of il-18 inhibitors
11/20/2002	EP1257281A1 Nucleoside analogs with carboxamidine modified monocyclic base
11/20/2002	EP1257269A1 Orally administrable acid stable anti-ulcer benzimidazole derivatives
11/20/2002	EP1257262A2 Pharmacological agent comprising picolinic acid, fusaric acid and derivatives thereof
11/20/2002	EP1257247A2 Propellant-containing tooth cleaning agent
11/20/2002	EP1257232A2 Oral therapeutic delivery appliance
11/20/2002	EP1162987B1 Pharmaceutical composition for medical and veterinary use for regenerating intestinal flora in diarrhoea or dyspeptic syndrome
11/20/2002	EP1150969B1 Alpha-azacyclomethyl quinoline derivatives for treating urinary incontinence
11/20/2002	EP1147101B1 Reverse hydroxamate inhibitors of matrix metalloproteinases
11/20/2002	EP1107732B1 Oral liquid mucoadhesive compositions
11/20/2002	EP1047688B1 Thiophene nitrone compounds
11/20/2002	EP1007522B1 2- 4-[4-(4,5-dichloro-2-methylimidazol-1-yl)butyl]piperazin-1-yl -5-fluoropyrimidine, its preparation and therapeutic use
11/20/2002	EP0984952B1 A new salt
11/20/2002	EP0814840B1 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a prokinetic agent
11/20/2002	EP0813424B1 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and an antacid agent or alginate
11/20/2002	EP0699199B1 Heteroatom substituted alkyl benzylaminoquinuclidines as substance p antagonists
11/20/2002	EP0547151B1 Treatment process for promoting weight loss employing a substituted delta 5-androstene
11/20/2002	CN1380829A Rapidly disintegrating table and process for manufacture thereof
11/20/2002	CN1380340A 重组乙肝病毒免疫球蛋白 Recombinant hepatitis B virus immune globulin
11/20/2002	CN1380096A Nokemei capsule and its production method
11/20/2002	CN1380094A Achillea total flavone capsule
11/20/2002	CN1380093A Alcohol extraction method for extracting grape skin extract and its grape liver-nourishing capsule
11/20/2002	CN1380084A Medicine for external application for curing diseases of digestive tract, repercussion and stopping pain and its preparation method
11/20/2002	CN1380080A Medicine for curing fatty liver
11/20/2002	CN1380079A Lozenge for removing oral abnormal smell and its preparation method
11/20/2002	CN1380078A Chinese medicine preparation for curing chronic enteritis
11/20/2002	CN1380076A Chinese medicine for curing motion sickness
11/20/2002	CN1380068A Medicine for curing enterogastric diseases and its preparation method
11/20/2002	CN1094491C 2-{4-[4-(4,5-methylimidazol-1-yl)butyl]-1-piperazinyl}-5-fluoropyrimiding, preparation and use thereof

1 ... 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 ... 1258